Low Level Lazer Therapy Effect on Vertebral Artery Blood Flow in Elderly With Cervical Disc Degeneration

September 2, 2023 updated by: Shymaa yussuf abo zaid, South Valley University
This study will include 60 elderly patients with cervical disc degeneration, from both gender who are aged from 60 - 75 years old.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

The 60 patients will divided into two groups, with 30 patients in each group. group(A): will receive low level lazer and exercises for three times per week for 12 weeks.

Group (B): will receive only exercises. Resistivity index of both right and left vertebral arteries will be measured before and after the 12 weeks.

Study Type

Interventional

Enrollment (Estimated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Egypt
      • Qinā, Egypt
        • Shymaa yussuf abo zaid
        • Contact:
        • Contact:
          • Shymaa Y Abo zaid, Doctoral
          • Phone Number: 01010941685 01010941685

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. elderly patients with age range between 60 and 75 years old.
  2. with cervical disc degeneration.

Exclusion Criteria:

  1. patients with uncontrolled hypertension.
  2. Patients with uncontrolled diabetes mellitus.
  3. Patients with severe cardiac or chest diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Lazer group
30 patients will receive low level lazer therapy 3 times per week for 12 weeks.
Radiation: Low level Lazer therapy
30 patients will receive low level lazer therapy 3 times a week for 12 weeks.
Other: Routine exercises
30 patients will receive only routine exercises 3 times a week for 12 weeks.
Other: Control group
30 patients will receive only exercises.
Other: Routine exercises
30 patients will receive only routine exercises 3 times a week for 12 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resistivity index of both right and left vertebral arteries
Time Frame: 12 weeks
Resistivity index of both right and left vertebral arteries will be measured before and after the 12 weeks.
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

South Valley University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

September 15, 2023

Primary Completion (Estimated)

October 1, 2023

Study Completion (Estimated)

January 1, 2024

Study Registration Dates

First Submitted

August 20, 2023

First Submitted That Met QC Criteria

September 2, 2023

First Posted (Actual)

September 6, 2023

Study Record Updates

Last Update Posted (Actual)

September 6, 2023

Last Update Submitted That Met QC Criteria

September 2, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T_int_08/2023_519

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Disc Degeneration

Clinical Trials on Low level Lazer therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe